Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncogenic KrasG12D causes myeloproliferation via NLRP3 inflammasome activation
Authors
Keywords
-
Journal
Nature Communications
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-03
DOI
10.1038/s41467-020-15497-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Juvenile myelomonocytic leukemia: who’s the driver at the wheel?
- (2019) Charlotte M. Niemeyer et al. BLOOD
- Development, application and computational analysis of high-dimensional fluorescent antibody panels for single-cell flow cytometry
- (2019) Jolanda Brummelman et al. Nature Protocols
- Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management
- (2018) Mrinal M. Patnaik et al. AMERICAN JOURNAL OF HEMATOLOGY
- Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells
- (2018) Nimitha R Mathew et al. NATURE MEDICINE
- Oncogenic JAK2 V617F causes PD-L1 expression, mediating immune escape in myeloproliferative neoplasms
- (2018) Alessandro Prestipino et al. Science Translational Medicine
- Blocking IL-1β reverses the immunosuppression in mouse breast cancer and synergizes with anti–PD-1 for tumor abrogation
- (2018) Irena Kaplanov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR in Tumor-Associated Myeloid Cells Promotes Development of Colorectal Cancer in Mice and Associates With Outcomes of Patients
- (2017) Sriram Srivatsa et al. GASTROENTEROLOGY
- RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells
- (2016) Ulrike Höckendorf et al. CANCER CELL
- K + Efflux-Independent NLRP3 Inflammasome Activation by Small Molecules Targeting Mitochondria
- (2016) Christina J. Groß et al. IMMUNITY
- Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
- (2016) Jane Merlevede et al. Nature Communications
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- RAS diseases in children
- (2014) C. M. Niemeyer HAEMATOLOGICA
- MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner
- (2013) T. Shindo et al. BLOOD
- The Nlrp3 inflammasome regulates acute graft-versus-host disease
- (2013) Dragana Jankovic et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Protein Synthesis in a Myc/mTOR-Driven Model of Anorexia-Cachexia Syndrome Delays Its Onset and Prolongs Survival
- (2011) F. Robert et al. CANCER RESEARCH
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- STAT-3 and ERK 1/2 phosphorylation are critical for T-cell alloactivation and graft-versus-host disease
- (2008) S. X. Lu et al. BLOOD
- Juvenile myelomonocytic leukemia: A report from the 2nd International JMML Symposium
- (2008) Rebecca J. Chan et al. LEUKEMIA RESEARCH
- Cryopyrinopathies: update on pathogenesis and treatment
- (2008) Bénédicte Neven et al. Nature clinical practice. Rheumatology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More